These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10746455)

  • 1. Recombinant kringle 1-3 of plasminogen inhibits rabbit corneal angiogenesis induced by angiogenin.
    Shin SH; Kim JC; Chang SI; Lee H; Chung SI
    Cornea; 2000 Mar; 19(2):212-7. PubMed ID: 10746455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
    Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
    Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
    Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct binding of recombinant plasminogen kringle 1-3 to angiogenin inhibits angiogenin-induced angiogenesis in the chick embryo CAM.
    Youn MR; Park MH; Choi CK; Ahn BC; Kim HY; Kang SS; Hong YK; Joe YA; Kim JS; You WK; Lee HS; Chung SI; Chang SI
    Biochem Biophys Res Commun; 2006 May; 343(3):917-23. PubMed ID: 16564503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo.
    Sharma A; Bettis DI; Cowden JW; Mohan RR
    Mol Vis; 2010 Apr; 16():720-8. PubMed ID: 20431722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiostatin inhibits and regresses corneal neovascularization.
    Ambati BK; Joussen AM; Ambati J; Moromizato Y; Guha C; Javaherian K; Gillies S; O'Reilly MS; Adamis AP
    Arch Ophthalmol; 2002 Aug; 120(8):1063-8. PubMed ID: 12149060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corneal transduction to inhibit angiogenesis and graft failure.
    Murthy RC; McFarland TJ; Yoken J; Chen S; Barone C; Burke D; Zhang Y; Appukuttan B; Stout JT
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):1837-42. PubMed ID: 12714613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of corneal neovascularization by rapamycin.
    Kwon YS; Kim JC
    Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis effects of nerve growth factor (NGF) on rat corneas.
    Seo K; Choi J; Park M; Rhee C
    J Vet Sci; 2001 Aug; 2(2):125-30. PubMed ID: 14614283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo significance of ICAM-1--dependent leukocyte adhesion in early corneal angiogenesis.
    Becker MD; Kruse FE; Azzam L; Nobiling R; Reichling J; Völcker HE
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):612-8. PubMed ID: 10067964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by bovine angiogenin of tubular morphogenesis and expression of plasminogen activator in bovine endothelial cells.
    Jimi S; Ito K; Kohno K; Ono M; Kuwano M; Itagaki Y; Ishikawa H
    Biochem Biophys Res Commun; 1995 Jun; 211(2):476-83. PubMed ID: 7540839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of triamcinolone acetonide on corneal neovascularization.
    Murata M; Shimizu S; Horiuchi S; Taira M
    Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):205-9. PubMed ID: 16044325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Corneal Neovascularization in Rabbits.
    Arai KI; Yasukawa T; Kato A; Kubota A; Usui H; Takase N; Kuwayama S; Ogura Y
    Ophthalmic Res; 2018; 59(3):170-175. PubMed ID: 29533953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel.
    Yang CF; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Tabata Y; Ikada Y; Ogura Y
    Ophthalmic Res; 2000; 32(1):19-24. PubMed ID: 10657751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenin ameliorates corneal opacity and neovascularization via regulating immune response in corneal fibroblasts.
    Lee SH; Kim KW; Joo K; Kim JC
    BMC Ophthalmol; 2016 May; 16():57. PubMed ID: 27356868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy.
    Drixler TA; Borel Rinkes IH; Ritchie ED; van Vroonhoven TJ; Gebbink MF; Voest EE
    Cancer Res; 2000 Mar; 60(6):1761-5. PubMed ID: 10749151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of plasminogen fragment on experimentally induced neovascularization of rat corneas.
    Murata M; Nakagawa M; Takahashi S
    Graefes Arch Clin Exp Ophthalmol; 1997 Sep; 235(9):584-6. PubMed ID: 9342609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor.
    Loughman MS; Chatzistefanou K; Gonzalez EM; Flynn E; Adamis AP; Shing Y; D'Amato RJ; Folkman J
    Aust N Z J Ophthalmol; 1996 Aug; 24(3):289-95. PubMed ID: 8913136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
    Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
    J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.